Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-005844

CEO sold 16,303 shares at $10.58 ($172,486)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-21 Sale : show line 1 in the form −16,303 $10.58 $172,486 772,680 D
Open-market sales · 16,303 sh · avg $10.58 · $172,486
Loading xslF345X05/form4.xml…